BioStem Technologies, Inc. (OTCMKTS:BSEM) Short Interest Up 152.7% in April

BioStem Technologies, Inc. (OTCMKTS:BSEM) was the recipient of a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 37,400 shares, an increase of 152.7% from the March 31st total of 14,800 shares. Based on an average trading volume of 68,700 shares, the short-interest ratio is presently 0.5 days.

BioStem Technologies Stock Down 3.1 %

BioStem Technologies stock traded down 0.30 during midday trading on Friday, hitting 9.11. 19,597 shares of the company were exchanged, compared to its average volume of 29,291. BioStem Technologies has a fifty-two week low of 1.20 and a fifty-two week high of 15.50. The stock’s fifty day simple moving average is 10.38.

BioStem Technologies (OTCMKTS:BSEM) last posted its earnings results on Monday, April 1st. The company reported -0.14 EPS for the quarter. The company had revenue of 11.44 million during the quarter, compared to analysts’ expectations of 11.40 million. Equities analysts expect that BioStem Technologies will post 3.14 EPS for the current year.

About BioStem Technologies

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.